A randomized comparison evaluating the value of high-sensitivity troponin in the efficient management of chest pain patients across the spectrum of risk for an acute coronary syndrome

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/1024008

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Chest pain patients are a large burden of emergency department demand. Their effective care requires timely risk assessment. High-sensitivity assays for cardiac muscle damage (troponin) increases the ability to detect patients with heart attacks, but may also lead to more abnormal results from other causes and more admissions. This randomized trial of current troponin versus a new troponin assays with robust initial evaluation of patient risk will provide a rationale for their use in modern care.

Funded Activity Details

Start Date: 01-01-2012

End Date: 01-01-2013

Funding Scheme: NHMRC Project Grants

Funding Amount: $508,567.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Cardiology (incl. Cardiovascular Diseases)

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

acute coronary syndromes | clinical effectiveness | clinical guidelines | clinical patient management | diagnostic assay | evaluation | randomised controlled trial (RCT) | risk assessment

Related Links